Thermo Fisher Scientific’s Inc (TMO – Q3FY20) – Exceptional performance in the quarter due to growth in Life Sciences Solutions segment.

in , on November 6, 2020

The company launched innovative Thermo Scientific products across businesses, highlighted by two Selectris imaging filters for cryo-electron microscopes that accelerate research in structural analysis of proteins, and the POROS Oligo (dT)25 Affinity Resin to advance mRNA-based therapies and vaccines.

Executive Summary

Financial Statements

– Income Statement and Forecast
– Balance Sheet
– Cash Flow
– Q3FY20 Results – Overview
– Q3FY20 – Segment Performance
– Q3FY20 – Key Developments
– FY20 Guidance
– Conclusion
– GAAP to Non-GAAP Reconciliation

Historical Performance

– Key Ratios
– Profitability Ratios, Asset Turnover Ratio, Growth Ratio
– Per Share Items and Key Ratios
– Key Balance Sheet and Cash Flow Items
– P/E Band

Product Performance and Key Developments

– Ownership
– Competitors
– Key Developments

Valuation and Consensus Performance

– Analyst Recommendations

Market Price Performance

CrispIdea Coverage

No of Pages : 44

Release Information

  • Released

    November 6, 2020

  • Last Updated

    November 6, 2020